Worldwide Emergence of Extensively Drug-resistant Tuberculosis

Mycobacterium tuberculosis strains that are resistant to an increasing number of second-line drugs used to treat multidrug-resistant tuberculosis (MDR TB) are becoming a threat to public health worldwide. We surveyed the Network of Supranational Reference Laboratories for M. tuberculosis isolates th...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Emerging infectious diseases Ročník 13; číslo 3; s. 380 - 387
Hlavní autoři:	Shah, N. Sarita, Wright, Abigail, Bai, Gill-Han, Barrera, Lucia, Boulahbal, Fadila, Martín-Casabona, Nuria, Drobniewski, Francis, Gilpin, Chris, Havelková, Marta, Lepe, Rosario, Lumb, Richard, Metchock, Beverly, Portaels, Françoise, Rodrigues, Maria Filomena, Rüsch-Gerdes, Sabine, Van Deun, Armand, Vincent, Veronique, Laserson, Kayla, Wells, Charles, Cegielski, J. Peter
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States U.S. National Center for Infectious Diseases 01.03.2007 Centers for Disease Control and Prevention
Témata:	Antitubercular Agents - pharmacology Communicable Disease Control Drug resistance in microorganisms emerging Global Health Health aspects Humans infectious diseases Laboratories multidrug-resistant Mycobacterium tuberculosis Mycobacterium tuberculosis - drug effects Public health second-line drugs Sentinel Surveillance tuberculosis Tuberculosis - drug therapy Tuberculosis - microbiology Tuberculosis - prevention & control Tuberculosis, Multidrug-Resistant United States Switzerland
ISSN:	1080-6040, 1080-6059
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!